Syndemics of Antimicrobial Resistance: Non-communicable Diseases, Social Deprivation, and the Rise of Multidrug-Resistant Infections
- PMID: 40610830
- PMCID: PMC12339799
- DOI: 10.1007/s40121-025-01188-1
Syndemics of Antimicrobial Resistance: Non-communicable Diseases, Social Deprivation, and the Rise of Multidrug-Resistant Infections
Abstract
Antimicrobial resistance (AMR) constitutes a global health emergency that results in significant morbidity, mortality, and economic burden. Despite its severity, this issue remains inadequately addressed in public health discussions worldwide. This commentary employs a syndemic perspective to explore the synergistic relationship between multidrug-resistant (MDR) infections and non-communicable chronic diseases (NCDs). NCDs, including cardiovascular disease, chronic respiratory conditions, cancer, and diabetes mellitus, are prevalent among socially deprived populations, creating conditions that facilitate bacterial colonization and worsen disease severity, thus heightening the risk of infection and resulting in poorer clinical outcomes. Conversely, MDR infections can also exacerbate NCDs by provoking inflammatory responses and disrupting homeostasis. The commentary further underscores how social determinants of health (SDoH), such as economic hardship, limited access to healthcare, and lower educational attainment, intensify this syndemic relationship, particularly in low- and middle-income countries (LMICs) and among socially deprived populations in high-income countries. In conclusion, we provide actionable recommendations for clinicians to consider when identifying and addressing syndemics in AMR. Embracing a syndemic approach to combat AMR may yield more effective strategies to alleviate the AMR "silent pandemic," especially benefiting populations disproportionately impacted by overlapping social, economic, and health vulnerabilities.
Keywords: Antimicrobial resistance; Multidrug-resistant infections; Non-communicable diseases; Poverty; Social deprivation; Social vulnerability; Syndemic.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflicts of Interest: Jacinda C Abdul-Mutakabbir has served on advisory boards and received honoraria from Shionogi, GSK, Pfizer, and CSL Seqirus, and receives support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) of the National Institutes of Health (NIH) under Award Number K12HD113189. Jacinda C Abdul-Mutakabbir is also a member of the advisory board for Infectious Diseases and Therapy. Jacinda C Abdul-Mutakabbir was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Raheem Abdul-Mutakabbir has no conflicts to disclose. Ethical Approval: This article is based on previous studies and contains no new studies with human participants or animals performed by authors.
Figures
Similar articles
-
Progress on the Global Research Agenda for Antimicrobial Resistance in Human Health in Pakistan: Findings and Implications.Infect Drug Resist. 2025 Jul 29;18:3795-3828. doi: 10.2147/IDR.S531874. eCollection 2025. Infect Drug Resist. 2025. PMID: 40761881 Free PMC article. Review.
-
Antimicrobials as cornerstones and quick fixes Zimbabwean in healthcare and society: Health practitioners´ critical reflections on two stories of antimicrobial use as part of antimicrobial resistance (AMR) education.PLOS Glob Public Health. 2025 Jul 7;5(7):e0004793. doi: 10.1371/journal.pgph.0004793. eCollection 2025. PLOS Glob Public Health. 2025. PMID: 40622964 Free PMC article.
-
Hail Lifestyle Medicine consensus position statement as a medical specialty: Middle Eastern perspective.Front Public Health. 2025 Jun 20;13:1455871. doi: 10.3389/fpubh.2025.1455871. eCollection 2025. Front Public Health. 2025. PMID: 40620567 Free PMC article.
-
Can We Lower the Burden of Antimicrobial Resistance (AMR) in Heavily Immunocompromised Patients? A Narrative Review and Call to Action.Infect Dis Ther. 2025 Aug 7. doi: 10.1007/s40121-025-01204-4. Online ahead of print. Infect Dis Ther. 2025. PMID: 40772992 Review.
-
Multidrug-resistant Klebsiella pneumoniae coinfection with multiple microbes: a retrospective study on its risk factors and clinical outcomes.mSystems. 2025 Jul 10:e0175724. doi: 10.1128/msystems.01757-24. Online ahead of print. mSystems. 2025. PMID: 40638073
References
-
- World Health Organization. Noncommunicable diseases. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. Accessed 12 May 2025.
Grants and funding
LinkOut - more resources
Full Text Sources